NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Emergent BioSolutions Inc. (NYSE: EBS) between April 24, 2020 through April 16, 2021, inclusive (the “Class Period”), of the important June 18, 2021 lead plaintiff deadline.

By A Silva